Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice.
Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice.
复制标题
DOI:
10.1080/10717544.2017.1279237
复制
发表时间:
2017-11
期刊:
影响因子:
6
通讯作者:
Masuzaki H
中科院分区:
文献类型:
--
作者:
Kozuka C;Shimizu-Okabe C;Takayama C;Nakano K;Morinaga H;Kinjo A;Fukuda K;Kamei A;Yasuoka A;Kondo T;Abe K;Egashira K;Masuzaki H
Our previous works demonstrated that brown rice-specific bioactive substance, γ-oryzanol acts as a chaperone, attenuates exaggerated endoplasmic reticulum (ER) stress in brain hypothalamus and pancreatic islets, thereby ameliorating metabolic derangement in high fat diet (HFD)-induced obese diabetic mice. However, extremely low absorption efficiency from intestine of γ-oryzanol is a tough obstacle for the clinical application. Therefore, in this study, to overcome extremely low bioavailability of γ-oryzanol with super-high lipophilicity, we encapsulated γ-oryzanol in polymer poly (DL-lactide-co-glycolide) (PLGA) nanoparticles (Nano-Orz), and evaluated its metabolically beneficial impact in genetically obese-diabetic ob/ob mice, the best-known severest diabetic model in mice. To our surprise, Nano-Orz markedly ameliorated fuel metabolism with an unexpected magnitude (∼1000-fold lower dose) compared with regular γ-oryzanol. Furthermore, such a conspicuous impact was achievable by its administration once every 2 weeks. Besides the excellent impact on dysfunction of hypothalamus and pancreatic islets, Nano-Orz markedly decreased ER stress and inflammation in liver and adipose tissue. Collectively, nanotechnology-based developments of functional foods oriented toward γ-oryzanol shed light on the novel approach for the treatment of a variety of metabolic diseases in humans.
登录
查看更多内容
影响因子:
7.7
作者:
Kozuka C;Yabiku K;Sunagawa S;Ueda R;Taira S;Ohshiro H;Ikema T;Yamakawa K;Higa M;Tanaka H;Takayama C;Matsushita M;Oyadomari S;Shimabukuro M;Masuzaki H
通讯作者:
Masuzaki H
影响因子:
3.7
作者:
Kamei A;Watanabe Y;Kondo K;Okada S;Shinozaki F;Ishijima T;Nakai Y;Kondo T;Arai S;Abe K
通讯作者:
Abe K
DOI:
10.1073/pnas.0504978102
发表时间:
2005-08-02
影响因子:
11.1
作者:
Ley, RE;Bäckhed, F;Gordon, JI
通讯作者:
Gordon, JI
影响因子:
5.5
作者:
Navarro, Sara M.;Morgan, Timothy W.;Sabliov, Cristina M.
通讯作者:
Sabliov, Cristina M.
DOI:
10.1056/nejmoa1014296
发表时间:
2011-06-23
期刊:
The New England journal of medicine
影响因子:
--
作者:
Mozaffarian D;Hao T;Rimm EB;Willett WC;Hu FB
通讯作者:
Hu FB